Dressing composition for promoting rapid healing of wound
The nanofiber dressing prepared by electrospinning process is combined with the nano-multi-tube pore structure hemostasis and antibacterial sponge substrate, which solves the problem of insufficient mechanical strength and antibacterial performance of wound dressing, and achieves the effect of rapid healing and efficient absorption of exudate.
Patent Information
- Application Number
- CN202411126379.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing wound dressings cannot meet the needs of rapid healing, high mechanical strength, good antibacterial properties, not easy to deform and good absorption of exudate.
The nanofibers prepared by electrospinning process of bioactive dressing solution are used as the upper dressing, combined with the nano-multi-tube pore structure hemostasis and antibacterial sponge substrate, and the bioactive dressing solution is oriented to the sponge surface through electrospinning process to form a Dressing composition with high hydrophobicity and high mechanical strength.
It achieves rapid healing, enhances mechanical strength, controls the release of anti-inflammatory and antibacterial substances, prevents external pollution, reduces the risk of infection and the pain of dressing replacement, and improves wound healing efficiency.
Smart Images

Figure BDA0004996539870000101 
Figure BDA0004996539870000111 
Figure BDA0004996539870000121
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedicine, in particular to a dressing composition for promoting rapid wound healing. Background Art
[0002] Wounds are generally referred to as damaged and torn areas of skin, muscle, mucous membranes, etc. in humans or other animals. Wound healing is the healing process of skin and other tissues after they have been broken or damaged, aiming to maintain the function and integrity of the damaged tissue. It is a multi-step process consisting of four overlapping phases: hemostasis, inflammation, proliferation, and dermal remodeling, which require a complex and coordinated interaction of various cell types and growth factors.
[0003] To date, a wide range of wound dressings have been developed to reduce inflammation, control wound infection, promote neovascularization, and enhance wound healing. Traditional wound dressing products include cotton wool, plasters, gauze, bandages (natural and synthetic), and cotton wool, which are used as primary or secondary dressings to protect wounds from contamination. Traditional wound dressings can prevent external infection of wounds. They have limited ability to effectively regulate moisture absorption by the wound, resulting in insufficient moisture and failure to heal quickly. Traditional wound dressings are generally used to dry and clean wounds.
[0004] The interactive and bioactive wound dressing group consists of hydrogels, semipermeable films, foam dressings, hydrocolloids, and hydrofibers. Hydrogels are hydrophilic, biocompatible, and permeable to nutrients and metabolites, making them non-irritating materials made from synthetic polymers. Hydrogel dressings are suitable for all four stages of wound healing, except for infected and heavily draining wounds, where low mechanical strength and the potential for skin infection are their main drawbacks. In addition, another commonly used wound dressing includes semipermeable membranes. Semipermeable membranes are specifically designed to treat non-exuding or low-exuding wounds. In addition, they also have unique properties such as transparency, elasticity, and flexibility, and are recommended for superficial and epithelialized wounds. Subsequently, semipermeable foam dressings consist of hydrophobic and hydrophilic foam materials, sometimes with an adhesive border. Typically, foam dressings are used as primary dressings due to their high water absorption and moisture permeability, eliminating the need for additional secondary dressings. Foam dressings can absorb varying amounts of wound drainage, depending on the thickness of the wound. Adhesive and non-adhesive foam dressings are available. Foam dressings are suitable for wounds with exudation and granulation. Bioactive wound dressings, i.e. hydrocolloids and hydrofibers, can promote healing and provide biocompatibility, biodegradability and non-toxicity. However, this type of dressing does not allow for water vapor exchange, which is a disadvantage for infected wounds that require oxygen to improve healing. They can be derived from a variety of sources, including natural tissues and artificial materials such as collagen, hyaluronic acid, chitosan oligosaccharides, alginates, elastin, dextran and gelatin. The use of bioactive dressings containing growth factors and antimicrobial agents can promote wound healing.
[0005] Electrospinning is an advanced technology that uses electricity to produce nanofibers. The process can produce nanofibers with diameters ranging from a few nanometers to several micrometers. Electrospinning is used in many medical fields, such as biomedicine, materials engineering, and electrical engineering. Nanofibers obtained by electrospinning generally have very small diameters, which is advantageous in various applications, especially in dressings. In addition, the structure of nanofibers produced by electrospinning has a large surface area relative to the volume, which is important in the context of adsorption, transport, and cellular interactions of substances that may occur in dressings. The high porosity may benefit the processes of wound healing, fluid absorption, and interaction with cells. In addition to regulating the structure and morphology, the structure, morphology, and mechanical properties of nanofibers can be tuned to specific application requirements by controlling the electrospinning parameters. Nanofiber-based products play a key role in wound healing because they have unique properties that help create a favorable microenvironment for the wound healing process. The extremely high surface area to volume ratio increases the adsorption and retention of bioactive molecules, growth factors, and other therapeutic agents on the surface of nanofibers, facilitating their controlled release to the wound site.
[0006] Although a variety of wound dressings have been developed and used in clinical practice, existing dressings still fail to meet certain requirements. Summary of the invention
[0007] The purpose of the present invention is to provide a dressing composition for promoting rapid wound healing, and to invent a dressing composition for promoting rapid wound healing that is hydrophobic to the outside, has increased mechanical strength, is not easy to deform, has good absorption of exudate, and has good antibacterial properties.
[0008] To achieve the above object, the present invention provides the following technical solutions:
[0009] A dressing composition for promoting rapid wound healing, comprising an upper dressing and a lower dressing: the upper dressing is nanofibers made from a bioactive dressing solution through an electrospinning process, and its main components are polycaprolactone, polyethylene oxide and plant extracts; the lower dressing is a hemostatic and antibacterial sponge base with a multi-tubular porous structure, and its main components are modified two-dimensional titanium carbide, chitosan oligosaccharides and calcium ions.
[0010] Furthermore, the preparation steps of the bioactive dressing solution are as follows:
[0011] S1, dissolving polycaprolactone particles at a concentration of 12 wt % in a FA:AA:Ac solvent system for 3 h to prepare a polycaprolactone solution;
[0012] S2. Prepare a polyethylene oxide solution by dissolving polyethylene oxide particles at a concentration of 15 wt % in distilled water for two days by dropping the plant extract under gentle stirring at 50°C;
[0013] S3. Mix the solutions prepared in S1 and S2 to obtain a bioactive dressing solution.
[0014] It should be noted that polycaprolactone is a synthetic polyester approved by the FDA for medical applications and is widely studied for use in tissue engineering and drug delivery due to its biocompatibility, biodegradability, non-toxicity, and excellent mechanical properties compared to natural polymers. However, for a given application in wound healing, the hydrophobicity of polycaprolactone may limit the absorption of wound exudate and the interaction with cells required for regeneration. Polyethylene oxide is a natural, biocompatible, water-soluble polymer widely used in the food and pharmaceutical industries for the release of active agents after dissolution in an aqueous environment.
[0015] Furthermore, in step S1 of preparing the bioactive dressing solution, the average relative molecular mass of PCL particles is 80,000 and the theoretical density is 1.145 g / cm 3 The weight ratio of the solvent system FA, AA and Ac is 1:1:1; the average molecular weight of PEO particles is 35,000, and the theoretical density is 0.45g / cm 3 .
[0016] Furthermore, in step S2 of preparing the bioactive dressing solution, the plant oil extracts are Hypericum perforatum flower oil extract and Calendula officinalis flower extract, and the active ingredients are hypericin and triterpenes, flavonoids, polyphenols and carotenoids, the content of which is 2-4% of the dressing composition for promoting rapid wound healing, and the mass ratio of Hypericum perforatum flower oil extract and Calendula officinalis flower extract is 1:1.
[0017] It should be noted that the active ingredient of the oil extract of Hypericum perforatum flower is hypericin, which has certain anti-inflammatory and antifungal activities; the active ingredients of calendula extract are triterpenoids, flavonoids, polyphenols and carotenoids, which can effectively inhibit various factors that cause inflammation, such as cytokines, enzymes and free radicals. These bioactive substances can reduce the production of inflammatory mediators and reduce the inflammatory response of tissues, thereby achieving anti-inflammatory effects.
[0018] Furthermore, in step S3 of preparing the bioactive dressing solution, the bioactive dressing solution prepared has a PCL concentration of 10 wt %, and a PCL:PEO weight ratio of (7-9):(1-3).
[0019] It should be noted that the bioactive dressing solution is used in the subsequent electrospinning process to prepare the outer layer fibers of the nano-multi-tubular porous structure hemostatic and antibacterial sponge base, that is, the nanofiber-based bioactive dressing, which can control the release of anti-inflammatory and antibacterial oily natural extracts, enhance mechanical strength, form a green, environmentally friendly and biocompatible hydrophobic layer, and prevent external pollution.
[0020] Further, the preparation steps of the nano multi-tubular porous structure hemostatic antibacterial sponge substrate are as follows:
[0021] S1. Disperse the prepared 5 mL MXene (5 mg / mL) in 45 mL ethanol / water (10 wt% ethanol) solution, ultrasonicate for 15 min, then drop 2 mL 3-aminopropyltriethoxysilane into the suspension and stir at room temperature for 24 h. After the reaction, wash the mixture with ethanol and deionized water to remove unbound 3-aminopropyltriethoxysilane molecules, and the resulting aminated MXene is referred to as MXene-NH2.
[0022] S2. Dissolve chitosan oligosaccharide in 45 mL of 0.5% acetic acid solution. Then add MXene-NH2 (2 mg / mL) to the system. After stirring evenly at room temperature, add calcium acetate to the mixture. After the reaction, cast the mixture into a mold and freeze-dry for 48 hours to obtain a nano-tubular porous structure hemostatic antibacterial sponge substrate; the dosage ratio of chitosan oligosaccharide, acetic acid, MXene-NH2 and calcium acetate is (0.8-1.2) g:45 mL:(4-6) mL:(1.6-2.4) mmol.
[0023] It should be noted that although chitosan oligosaccharides and MXene have antibacterial activity, their antibacterial effect is not long-lasting, their ability to promote wound healing is not high, and their remodeling ability is weak. Calcium ion is an excellent antibacterial agent. It not only has high antibacterial activity, but also can act as a coagulation factor, participate in the coagulation process, increase metabolic activity, promote collagen synthesis and cytokine expression, reduce cell contraction ability, and ultimately achieve infection control and accelerate wound healing. However, when calcium ions are simply mixed with chitosan oligosaccharides and MXene to prepare hemostatic sponges, they will release a large amount of calcium ions in a short period of time, causing cumulative toxicity to the human body. Therefore, it is necessary to design a dressing that can control the release of calcium ions. Ca 2+ It has high covalency and abundant coordination sites, and can interact with substances containing amino, carboxyl, hydroxyl and other groups to form a point-line-surface topological structure, stabilize the system structure, and achieve controlled release of active ingredients.
[0024] Furthermore, in step S1 of preparing the nano multi-tubular porous structure hemostatic antibacterial sponge substrate, the chitosan oligosaccharide has a relative molecular weight of 2600-3000 and a degree of polymerization of 16-18;
[0025] It should be noted that chitosan oligosaccharide, also known as oligochitosan, is the only positively charged cationic alkaline amino oligosaccharide in nature. It is an animal cellulose with the advantages of low molecular weight, good water solubility, great functional effects, easy absorption by the human body, and high biological activity.
[0026] Furthermore, the MXene in step S1 of preparing the nano-multi-tubular porous structure hemostatic antibacterial sponge substrate is prepared by the following steps:
[0027] 1 g LiF was dissolved in 20 mL hydrochloric acid (9 mol / L), and then 1 g Ti3AlC2 was added. The mixture was stirred continuously and reacted at 35 °C for 24 h. After the reaction, the mixture was washed to neutrality and then centrifuged at 4000 r / min to collect the supernatant. Finally, a high-concentration MXene solution was obtained by rotary evaporation and stored at 4 °C.
[0028] It should be noted that MXene is a two-dimensional material composed of transition metal carbides, nitrides or carbonitrides, which has good biocompatibility and biosafety. MXene nanosheets can destroy the integrity of bacterial cell membranes, and the large specific surface area enhances the effective contact between the material and bacteria, thereby showing good antibacterial activity. However, there are a large number of hydrophilic surface functional groups on the surface of MXene, which are easily oxidized in a water-oxygen environment. There are a series of disadvantages in the body, including poor water dispersibility and slow degradation. Its high hydrophilicity is not conducive to wound healing, so it is modified to protect stability and adjust hydrophilicity. On the one hand, calcium ions are complexed with the amino groups on chitosan oligosaccharides, and on the other hand, they are complexed with the rich amino groups on the surface of aminated MXene to form a topologically cross-linked multi-tubular porous structure, which helps to solve the problems of poor sponge adsorption capacity, easy deformation of the structure during use, and weak antibacterial properties. Generally, sponges have large pores and partially present a unidirectional porous structure, while the pore size of the nano-multi-tubular porous structure hemostatic antibacterial sponge prepared by the present invention is narrowed and uniform, and many bridges are formed between the layered pore walls, dividing the originally long pores into smaller micropores, forming a complex staggered porous network structure inside the sponge. In addition, the channel structure is firm and does not collapse, showing better molding ability. The pore structure formed by cross-linking of chitosan oligosaccharides with aminated MXene and calcium ions is conducive to the aggregation of red blood cells and platelets, and the absorption of exudates and exuded blood. The multi-microtubular pore structure formed by the nano-hemostatic antibacterial sponge can be used as a "regulating valve" to control the release of plant extracts in the outer dressing to act on the wound through the sponge.
[0029] Further, the prepared nano multi-tubular porous structure hemostatic antibacterial sponge substrate is fixed on a high-speed orientation receiver, and the prepared bioactive dressing solution is directional electrospun onto the sponge surface to obtain a dressing composition that promotes rapid wound healing. The specific steps are as follows:
[0030] The alternating current needle electrospinning method was used, based on the bioactive dressing solution placed in a 5mL syringe coupled to an 18G needle; the flow rate was adjusted to 2mL / h, and a rectangular Instek GW MFG2120MA signal generator (30Hz) was applied using a TREK10 / 40A-HS amplifier (10kV) to create an input signal. The nano-tubular porous structure hemostatic antibacterial sponge substrate was fixed on a high-speed orientation receiver with a fixed rotation speed of 40r / min and a fixed needle collector distance of 15cm.
[0031] It should be noted that the nanofiber-based bioactive dressing, as the outer layer fiber of the nano-multi-tubular porous structure hemostatic antibacterial sponge base, can, on the one hand, control the release of anti-inflammatory and antibacterial natural extracts, and on the other hand, can improve the mechanical strength at the microscopic level, forming a green, environmentally friendly, biocompatible hydrophobic layer to prevent external pollution. In terms of wound healing applications, compared with the direct use of hemostatic antibacterial sponges, it can reduce the frequency of wound dressing applications, thereby limiting the risk of infection, the use of antibiotics, and the pain associated with dressing changes.
[0032] Compared with the prior art, the present invention has the following beneficial effects:
[0033] The nanofiber-based bioactive dressing is the outer fiber of the nano-multi-tubular porous structure hemostatic and antibacterial sponge base. On the one hand, it can control the release of anti-inflammatory and antibacterial natural extracts, and on the other hand, it can improve the mechanical strength at the microscopic level, forming a green, environmentally friendly, biocompatible hydrophobic layer to prevent external pollution.
[0034] The calcium ions in the base of the nano-tubular porous structure hemostatic antibacterial sponge are complexed with the amino groups on the chitosan oligosaccharide and the modified MXene to form a topologically cross-linked tubular porous structure. The pore size of the sponge becomes narrower and uniform, and many bridges are formed between the layered pore walls, dividing the originally long pores into smaller micropores, forming a complex staggered porous network structure inside the sponge. The channel structure is firm and does not collapse, showing better molding ability, which is conducive to the aggregation of red blood cells and platelets, and the absorption of exudates and exuded blood. It helps to solve the problems of poor sponge adsorption capacity, easy deformation of the structure during use, and weak antibacterial properties. The multi-microtubular porous structure formed by the nano-tubular porous structure hemostatic antibacterial sponge can also be used as a "regulating valve" to control the release of plant extracts in the outer dressing to act on the wound through the sponge to achieve anti-inflammatory and antibacterial effects. DETAILED DESCRIPTION
[0035] The following will be described clearly and completely in conjunction with the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0036] Example 1
[0037] Step 1: prepare the bioactive dressing solution. The specific steps are as follows:
[0038] S1, dissolving polycaprolactone particles at a concentration of 12 wt % in a FA:AA:Ac solvent system for 3 h to prepare a polycaprolactone solution;
[0039] S2. Prepare a polyethylene oxide solution by dissolving polyethylene oxide particles at a concentration of 15 wt % in distilled water for two days by dropping the plant extract under gentle stirring at 50°C;
[0040] S3. Mix the solutions prepared in S1 and S2 to obtain a bioactive dressing solution.
[0041] The PCL concentration of the bioactive dressing solution is 10wt%, and the weight ratio of PCL:PEO is 7:3; the content of the Hypericum perforatum flower oily extract and the Calendula officinalis extract is 2% of the dressing composition for promoting rapid wound healing, and the mass ratio of the Hypericum perforatum flower oily extract and the Calendula officinalis extract is 1:1.
[0042] Step 2: Prepare a nano multi-tubular porous structure hemostatic antibacterial sponge, the specific steps are as follows:
[0043] S1. Dissolve 1g LiF in 20mL hydrochloric acid (9mol / L), then add 1g Ti3AlC2, stir the mixture continuously, and react at 35°C for 24h. After the reaction, wash the mixture to neutrality, then centrifuge at 4000r / min to collect the supernatant. Finally, obtain a high-concentration MXene solution by rotary evaporation and store at 4°C.
[0044] S2, disperse the prepared 5mL MXene (5mg / mL) in 45mL ethanol / water (10wt% ethanol) solution, ultrasonicate for 15min, then add 2mL 3-aminopropyltriethoxysilane dropwise to the suspension and stir at room temperature for 24h. After the reaction, wash the mixture with ethanol and deionized water to remove unbound 3-aminopropyltriethoxysilane molecules, and the resulting aminated MXene is referred to as MXene-NH2;
[0045] S3. Dissolve chitosan oligosaccharide in 45 mL of 0.5% acetic acid solution. Then add MXene-NH2 (2 mg / mL) to the system. After stirring evenly at room temperature, add calcium acetate to the mixture. After the reaction, cast the mixture into a mold and freeze-dry for 48 hours to obtain a nano-tubular porous structure hemostatic antibacterial sponge substrate; the dosage ratio of chitosan oligosaccharide, acetic acid, MXene-NH2 and calcium acetate is 0.8 g:45 mL:4 mL:1.6 mmol.
[0046] Step 3, using AC needle electrospinning, the bioactive dressing solution was placed in a 5mL syringe coupled to an 18G needle; the flow rate was adjusted to 2mL / h, and a rectangular InstekGW MFG 2120MA signal generator (30Hz) was used to create the input signal using a TREK10 / 40A-HS amplifier (10kV). The nano-multi-tubular porous structure hemostatic antibacterial sponge substrate was fixed on a high-speed orientation receiver with a fixed rotation speed of 40r / min and a fixed needle collector distance of 15cm.
[0047] Example 2
[0048] The steps are the same as those in Example 1, but the differences from Example 1 are as follows:
[0049] In step 1, the weight ratio of PCL:PEO in the bioactive dressing solution is 8:2; the content of the Hypericum perforatum flower oil extract and the Calendula officinalis extract is 3% of the dressing composition for promoting rapid wound healing, and the mass ratio of the Hypericum perforatum flower oil extract and the Calendula officinalis extract is 1:1.
[0050] In step 2, the dosage ratio of chitosan oligosaccharide, acetic acid, MXene-NH2 and calcium acetate is 1 g:45 mL:5 mL:2 mmol.
[0051] Example 3
[0052] The steps are the same as those in Example 1, but the differences from Example 1 are as follows:
[0053] In step 1, the weight ratio of PCL:PEO in the bioactive dressing solution is 9:1; the content of the Hypericum perforatum flower oil extract and the Calendula officinalis extract is 4% of the dressing composition for promoting rapid wound healing, and the mass ratio of the Hypericum perforatum flower oil extract and the Calendula officinalis extract is 1:1.
[0054] In step 2, the dosage ratio of chitosan oligosaccharide, acetic acid, MXene-NH2 and calcium acetate is 1.2 g:45 mL:6 mL:2.4 mmol.
[0055] Comparative Example 1
[0056] The steps are synchronized with Example 2, and the differences from Example 2 are as follows:
[0057] No plant extracts are added in step one.
[0058] Comparative Example 2
[0059] The steps are synchronized with Example 2, and the differences from Example 2 are as follows:
[0060] In step 2, no chitosan oligosaccharide was added, and the dosage ratio of acetic acid, MXene-NH2 and calcium acetate was 45 mL:6 mL:2.4 mmol.
[0061] Comparative Example 3
[0062] The steps are synchronized with Example 2, and the differences from Example 2 are as follows:
[0063] In step 2, no MXene was prepared, no MXene-NH2 was added, and the dosage ratio of chitosan oligosaccharide, acetic acid and calcium acetate was 1.2 g:45 mL:2.4 mmol.
[0064] Comparative Example 4
[0065] The steps are synchronized with Example 2, and the differences from Example 2 are as follows:
[0066] In step 2, no calcium acetate was added, and the dosage ratio of chitosan oligosaccharide, acetic acid and MXene-NH2 was 1.2 g:45 mL:6 mL.
[0067] test:
[0068] 1. Contact angle test
[0069] The wettability of the dressing composition was measured by contact angle measurement using Dataphysics OCA 15EC Neurtek optical equipment by dropping ultrapure water (2 μL per drop) (n=10). The test results are as follows:
[0070]
[0071] Table 1
[0072] 2. Absorption capacity test
[0073] The absorbent capacity of the dressing composition was determined using the free expansion absorbent capacity method according to UNE-EN ISO 13726-1:2002. The standard sample is 0.5 cm 2 , weigh the sample before testing and immerse it in test solution A (8.298g sodium chloride and 0.368g calcium chloride dihydrate dissolved in 1L deionized water) at 37±1℃. The ion composition of test solution A is similar to that of human serum or wound exudate. After 30 minutes, weigh the sample again. The absorption capacity is calculated as follows:
[0074] Absorption capacity (%) = (W t -W0) / W0×100%
[0075] W0-Sample quality before testing
[0076] W t - Sample quality after testing
[0077] The test results are as follows:
[0078] Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 Absorption capacity (%) 423.7 436.3 429.8 421.4 225.0 176.3 115.2
[0079] Table 2
[0080] 3. In vitro coagulation test
[0081] The dressing composition was cut into small cylinders and placed in a 25 mL beaker. After preheating at 37°C for 3 min, 0.1 mL of anticoagulated rabbit whole blood (0.2 M CaCl2, 10 mM blood) was dripped onto the inner surface of the dressing composition. The beaker was heated in a water bath at 37°C for 5 min, and then 10 mL of distilled water was added to wash the unbound red blood cells in the sponge. The absorbance of the sample (A i ). The absorbance (A0) of 0.1 mL of rabbit whole blood dissolved in 10 mL of distilled water was used as a blank control. The blood coagulation index (BCI) is a performance evaluation parameter for evaluating the performance of hemostatic materials in inducing blood thrombosis. The lower the BCI value, the better the coagulation effect of the hemostatic material, and vice versa. The blood coagulation index (BCI) calculation formula is as follows:
[0082] BCI (%) = (A0-A i ) / A0×100%
[0083] The test results are as follows:
[0084] Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 BCI (%) 0.06 0.06 0.06 0.13 0.43 0.51 0.93
[0085] Table 3
[0086] IV. Cumulative release experiment
[0087] The dressing composition was incubated in a 15 mL tube containing 10 mL of PBS solution (pH = 7.4), 0.5 mL of the solution was taken at set time intervals at 37°C, and fresh PBS solution was added to maintain a constant total volume. The solutions taken at different time periods were added to 4.5 mL of nitric acid, and the calcium ion concentration was measured using an inductively coupled plasma optical emission spectrometer (ICP-OES).
[0088] The test results are as follows:
[0089]
[0090] Table 4
[0091] 5. Antibacterial activity test
[0092] The agar diffusion method was used to evaluate the in vitro antibacterial properties of the dressing composition. First, the sample was sterilized under ultraviolet light for 30 min to activate the bacterial suspension (Escherichia coli, Staphylococcus aureus) with a density of about 10 5CFU / mL, prepared using 0.9% sterile saline. Subsequently, 10 mL of beef extract peptone agar medium was poured into a sterile culture dish, and Escherichia coli and Staphylococcus aureus were inoculated after the culture medium solidified. The sterilized sponge was then spread on the culture medium, and the culture dish was placed in a constant temperature and humidity incubator (37°C) for 24 hours, and the antibacterial performance was evaluated by measuring the diameter of the inhibition zone.
[0093] The test results are as follows:
[0094]
[0095] Table 5
[0096] VI. Conclusion
[0097] 1. Example 2 and Comparative Examples 1-4 Compared with Examples 1 and 3, it can be seen that when the ratio of PCL and PEO in the outer dressing is 8:2, the contact angle is the largest and the hydrophobicity is the best.
[0098] 2. The absorption capacity of exudate in Comparative Example 1 is not much different from that in Examples 1-3, indicating that the addition of plant extracts has little effect on the ability of the dressing composition to absorb exudate; the absorption capacity of exudate in Comparative Examples 2-4 is significantly reduced compared with Examples 1-3, especially in Comparative Example 4, indicating that the multi-microtubular pore structure formed by cross-linking of chitosan oligosaccharides with aminated MXene and calcium ions in the sponge plays a major role in absorbing exudate, and all three are indispensable, with the degree of influence being: calcium ions>aminated MXene>chitosan oligosaccharides.
[0099] 3. The coagulation effects of Examples 1-3 are better than those of Comparative Examples 1-4, among which the coagulation effect of Comparative Example 1 is significantly better than that of Comparative Examples 2-4, indicating that the addition of plant extracts has little effect on the coagulation ability of the dressing composition; Comparative Examples 2-3 still retain a certain coagulation ability, but the coagulation ability is significantly reduced compared with that of Examples 1-3, indicating that the aminated MXene and chitosan oligosaccharide have a greater effect on the coagulation ability of the dressing composition; Comparative Example 4 has almost no coagulation ability, indicating that calcium ions play a major role in the formation of the cross-linked network and tubular pore structure in the sponge, and the lack of the nano-multi-tubular pore structure directly leads to the lack of coagulation ability.
[0100] 4. The calcium ion release rate of Comparative Example 1 is relatively fast, and pathological toxicity is likely to occur in practical applications; Comparative Examples 2-3 not only have too fast calcium ion release rates, but also have small release amounts, which have little effect on inducing wound healing; Comparative Example 4 does not add calcium acetate, so it is not involved in the experiment and discussion.
[0101] 5. The antibacterial effects of Examples 1-3 are better than those of Comparative Examples 1-4, and the antibacterial effects of Comparative Examples 2-3 are better than those of Comparative Examples 1 and 4, indicating that plant extracts and calcium ions play a major antibacterial role in the dressing composition, and aminated MXene and chitosan oligosaccharide play a secondary antibacterial role in the dressing composition.
[0102] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A dressing composition for promoting rapid wound healing, characterized in that: It includes an upper dressing and a lower dressing; the upper dressing is nanofiber made from a bioactive dressing solution through an electrospinning process; the lower dressing is a hemostatic and antibacterial sponge base with a multi-tubular porous structure.
2. A dressing composition for promoting rapid wound healing according to claim 1, characterized in that: The preparation steps of the bioactive dressing solution are as follows: S1, dissolving PCL particles at a concentration of 12 wt % in a FA:AA:Ac solvent system for 3 h to prepare a PCL solution; S2, dissolving PEO particles at a concentration of 15 wt % in distilled water for two days at 50° C. with gentle stirring by dropping the plant oil extract to prepare a PEO solution; S3. Mix the solutions prepared in S1 and S2 to obtain a bioactive dressing solution.
3. The preparation process of the bioactive dressing solution according to claim 2, characterized in that: The average molecular weight of PCL particles in S1 is 80,000, and the theoretical density is 1.145 g / cm 3 The weight ratio of the solvent system FA, AA and Ac is 1:1:1; the average molecular weight of PEO particles is 35,000, and the theoretical density is 0.45g / cm 3 .
4. The preparation process of the bioactive dressing solution according to claim 2, characterized in that: The plant oil extracts described in S2 are Hypericum perforatum flower oil extract and Calendula officinalis flower extract, and the active ingredients are hypericin and triterpenes, flavonoids, polyphenols and carotenoids, the content of which is 2-4% of the dressing composition for promoting rapid wound healing, and the mass ratio of Hypericum perforatum flower oil extract and Calendula officinalis flower extract is 1:
1.
5. The preparation process of the bioactive dressing solution according to claim 2, characterized in that: In the bioactive dressing solution S3, the PCL concentration was maintained at 10wt%, and the weight ratio of PCL:CHI was (7-9):(1-3).
6. A dressing composition for promoting rapid wound healing according to claim 1, characterized in that: The steps for preparing the multi-tubular porous structure hemostatic antibacterial sponge substrate are as follows: S1. Disperse 5 mL of the prepared two-dimensional titanium carbide solution with a concentration of 5 mg / mL in 45 mL of an ethanol solution with a concentration of 10.0 wt%, ultrasonically treat for 15 min, then drop 2 mL of 3-aminopropyltriethoxysilane into the suspension and stir at room temperature for 24 h; after the reaction, wash the mixture with ethanol and deionized water to remove unbound 3-aminopropyltriethoxysilane molecules, and the resulting modified aminated two-dimensional titanium carbide is recorded as MXene-NH2; S2. Dissolve chitosan oligosaccharide in 45 mL of 0.5% acetic acid solution, and then add MXene-NH2 with a concentration of 2 mg / mL into the system; after stirring evenly at room temperature, add calcium acetate to the mixture; after the reaction, cast the mixture into a mold and freeze-dry for 48 hours to obtain a nano-multi-tubular porous structure hemostatic and antibacterial sponge substrate.
7. The preparation steps of the hemostatic and antibacterial sponge substrate with a multi-tubular porous structure according to claim 6 are characterized by: The dosage ratio of chitosan oligosaccharide, acetic acid, MXene-NH2 and calcium acetate in S2 is (0.8-1.2) g:45 mL:(4-6) mL:(1.6-2.4) mmol; the relative molecular weight of the chitosan oligosaccharide is 2600-3000, and the degree of polymerization is 16-18.
8. The preparation steps of the hemostatic and antibacterial sponge substrate with a multi-tubular porous structure according to claim 6 are characterized by: The two-dimensional titanium carbide is prepared by the following steps: 1 g LiF was dissolved in 20 mL 9 mol / L hydrochloric acid, and then 1 g Ti3AlC2 was added. The mixture was stirred continuously and reacted at 35°C for 24 h. After the reaction, the mixture was washed to neutrality and then centrifuged at 4000 r / min to collect the supernatant. Finally, a high-concentration two-dimensional titanium carbide solution was obtained by rotary evaporation and stored at 4°C.
9. The dressing composition for promoting rapid wound healing according to claim 1, characterized in that: The prepared multi-tubular pore structure hemostatic antibacterial sponge substrate is fixed on a high-speed orientation receiver, and the prepared bioactive dressing solution is directional electrospun onto the sponge surface to obtain a dressing composition that promotes rapid wound healing. The specific steps are as follows: The AC needle electrospinning method was used, and the bioactive dressing solution was placed in a 5mL syringe coupled with an 18G needle; the flow rate was adjusted to 2mL / h, and a rectangular Instek GW MFG 2120MA signal generator was used to create the input signal using a TREK10 / 40A-HS amplifier; the multi-tubular porous structure hemostatic antibacterial sponge substrate was fixed on a high-speed orientation receiver with a fixed rotation speed of 40r / min and a fixed needle collector distance of 15cm.
